Literature DB >> 23677991

Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.

David C Chiara1, Selwyn S Jayakar, Xiaojuan Zhou, Xi Zhang, Pavel Y Savechenkov, Karol S Bruzik, Keith W Miller, Jonathan B Cohen.   

Abstract

GABA type A receptors (GABAAR), the brain's major inhibitory neurotransmitter receptors, are the targets for many general anesthetics, including volatile anesthetics, etomidate, propofol, and barbiturates. How such structurally diverse agents can act similarly as positive allosteric modulators of GABAARs remains unclear. Previously, photoreactive etomidate analogs identified two equivalent anesthetic-binding sites in the transmembrane domain at the β(+)-α(-) subunit interfaces, which also contain the GABA-binding sites in the extracellular domain. Here, we used R-[(3)H]5-allyl-1-methyl-5-(m-trifluoromethyl-diazirynylphenyl) barbituric acid (R-mTFD-MPAB), a potent stereospecific barbiturate anesthetic, to photolabel expressed human α1β3γ2 GABAARs. Protein microsequencing revealed that R-[(3)H]mTFD-MPAB did not photolabel the etomidate sites at the β(+)-α(-) subunit interfaces. Instead, it photolabeled sites at the α(+)-β(-) and γ(+)-β(-) subunit interfaces in the transmembrane domain. On the (+)-side, α1M3 was labeled at Ala-291 and Tyr-294 and γ2M3 at Ser-301, and on the (-)-side, β3M1 was labeled at Met-227. These residues, like those in the etomidate site, are located at subunit interfaces near the synaptic side of the transmembrane domain. The selectivity of R-etomidate for the β(+)-α(-) interface relative to the α(+)-β(-)/γ(+)-β(-) interfaces was >100-fold, whereas that of R-mTFD-MPAB for its sites was >50-fold. Each ligand could enhance photoincorporation of the other, demonstrating allosteric interactions between the sites. The structural heterogeneity of barbiturate, etomidate, and propofol derivatives is accommodated by varying selectivities for these two classes of sites. We hypothesize that binding at any of these homologous intersubunit sites is sufficient for anesthetic action and that this explains to some degree the puzzling structural heterogeneity of anesthetics.

Entities:  

Keywords:  Anesthetics; Barbiturates; Cys Loop Receptors; Etomidate; GABA Receptors; Nicotinic Acetylcholine Receptors; Photoaffinity Labeling; Propofol

Mesh:

Substances:

Year:  2013        PMID: 23677991      PMCID: PMC3707639          DOI: 10.1074/jbc.M113.479725

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Refined structure of the nicotinic acetylcholine receptor at 4A resolution.

Authors:  Nigel Unwin
Journal:  J Mol Biol       Date:  2005-01-25       Impact factor: 5.469

Review 2.  Emerging molecular mechanisms of general anesthetic action.

Authors:  Hugh C Hemmings; Myles H Akabas; Peter A Goldstein; James R Trudell; Beverley A Orser; Neil L Harrison
Journal:  Trends Pharmacol Sci       Date:  2005-10       Impact factor: 14.819

3.  Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog.

Authors:  Guo-Dong Li; David C Chiara; Gregory W Sawyer; S Shaukat Husain; Richard W Olsen; Jonathan B Cohen
Journal:  J Neurosci       Date:  2006-11-08       Impact factor: 6.167

4.  X-ray structure of a prokaryotic pentameric ligand-gated ion channel.

Authors:  Ricarda J C Hilf; Raimund Dutzler
Journal:  Nature       Date:  2008-03-05       Impact factor: 49.962

5.  Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel.

Authors:  Ricarda J C Hilf; Raimund Dutzler
Journal:  Nature       Date:  2008-11-05       Impact factor: 49.962

Review 6.  General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal.

Authors:  Nicholas P Franks
Journal:  Nat Rev Neurosci       Date:  2008-05       Impact factor: 34.870

7.  Synthesis of trifluoromethylaryl diazirine and benzophenone derivatives of etomidate that are potent general anesthetics and effective photolabels for probing sites on ligand-gated ion channels.

Authors:  S Shaukat Husain; Selvanayagam Nirthanan; Dirk Ruesch; Ken Solt; Qi Cheng; Guo-Dong Li; Enrique Arevalo; Richard W Olsen; Douglas E Raines; Stuart A Forman; Jonathan B Cohen; Keith W Miller
Journal:  J Med Chem       Date:  2006-08-10       Impact factor: 7.446

8.  Synthesis and properties of 3-(2-hydroxyethyl)-3-n-pentyldiazirine, a photoactivable general anesthetic.

Authors:  S S Husain; S A Forman; M A Kloczewiak; G H Addona; R W Olsen; M B Pratt; J B Cohen; K W Miller
Journal:  J Med Chem       Date:  1999-08-26       Impact factor: 7.446

9.  Identification of a molecular target mediating the general anesthetic actions of pentobarbital.

Authors:  Anja Zeller; Margarete Arras; Rachel Jurd; Uwe Rudolph
Journal:  Mol Pharmacol       Date:  2006-12-12       Impact factor: 4.436

10.  Relative potencies for barbiturate binding to the Torpedo acetylcholine receptor.

Authors:  B A Dodson; R R Urh; K W Miller
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

View more
  75 in total

1.  A Cysteine Substitution Probes β3H267 Interactions with Propofol and Other Potent Anesthetics in α1β3γ2L γ-Aminobutyric Acid Type A Receptors.

Authors:  Alex T Stern; Stuart A Forman
Journal:  Anesthesiology       Date:  2016-01       Impact factor: 7.892

2.  γ-Aminobutyric Acid Type A Receptor Modulation by Etomidate Analogs.

Authors:  Ervin Pejo; Peter Santer; Lei Wang; Philip Dershwitz; S Shaukat Husain; Douglas E Raines
Journal:  Anesthesiology       Date:  2016-03       Impact factor: 7.892

3.  Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors.

Authors:  Manish Kumar; Glenn H Dillon
Journal:  Eur J Pharmacol       Date:  2016-02-09       Impact factor: 4.432

Review 4.  Structural models of ligand-gated ion channels: sites of action for anesthetics and ethanol.

Authors:  Richard W Olsen; Guo-Dong Li; Martin Wallner; James R Trudell; Edward J Bertaccini; Erik Lindahl; Keith W Miller; Ronald L Alkana; Daryl L Davies
Journal:  Alcohol Clin Exp Res       Date:  2013-10-24       Impact factor: 3.455

5.  Alphaxalone Binds in Inner Transmembrane β+-α- Interfaces of α1β3γ2 γ-Aminobutyric Acid Type A Receptors.

Authors:  Alexis M Ziemba; Andrea Szabo; David W Pierce; Marian Haburcak; Alex T Stern; Anahita Nourmahnad; Elizabeth S Halpin; Stuart A Forman
Journal:  Anesthesiology       Date:  2018-02       Impact factor: 7.892

6.  Human α1β3γ2L gamma-aminobutyric acid type A receptors: High-level production and purification in a functional state.

Authors:  Zuzana Dostalova; Xiaojuan Zhou; Aiping Liu; Xi Zhang; Yinghui Zhang; Rooma Desai; Stuart A Forman; Keith W Miller
Journal:  Protein Sci       Date:  2013-12-16       Impact factor: 6.725

7.  Analogues of etomidate: modifications around etomidate's chiral carbon and the impact on in vitro and in vivo pharmacology.

Authors:  Ervin Pejo; Peter Santer; Spencer Jeffrey; Hilary Gallin; S Shaukat Husain; Douglas E Raines
Journal:  Anesthesiology       Date:  2014-08       Impact factor: 7.892

8.  Tryptophan and Cysteine Mutations in M1 Helices of α1β3γ2L γ-Aminobutyric Acid Type A Receptors Indicate Distinct Intersubunit Sites for Four Intravenous Anesthetics and One Orphan Site.

Authors:  Anahita Nourmahnad; Alex T Stern; Mayo Hotta; Deirdre S Stewart; Alexis M Ziemba; Andrea Szabo; Stuart A Forman
Journal:  Anesthesiology       Date:  2016-12       Impact factor: 7.892

9.  Discovery of allosteric modulators for GABAA receptors by ligand-directed chemistry.

Authors:  Kei Yamaura; Shigeki Kiyonaka; Tomohiro Numata; Ryuji Inoue; Itaru Hamachi
Journal:  Nat Chem Biol       Date:  2016-08-15       Impact factor: 15.040

10.  A potent photoreactive general anesthetic with novel binding site selectivity for GABAA receptors.

Authors:  Abdelrahman R Shalabi; Zhiyi Yu; Xiaojuan Zhou; Youssef Jounaidi; Hanwen Chen; Jiajia Dai; Daniel E Kent; Hua-Jun Feng; Stuart A Forman; Jonathan B Cohen; Karol S Bruzik; Keith W Miller
Journal:  Eur J Med Chem       Date:  2020-03-23       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.